EVALUATION OF NEW DRUGS IN UNTREATED PATIENTS WITH SMALL-CELL LUNG-CANCER - ITS TIME HAS COME

被引：41

作者：

ETTINGER, DS

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1990年 / 8卷 / 03期

关键词：

D O I：

10.1200/JCO.1990.8.3.374

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：374 / 377

页数：4

相关论文

共 25 条

[1]

AISNER J, 1987, CANCER TREAT REP, V71, P1131

[2] EPIRUBICIN IN EXTENSIVE SMALL-CELL LUNG-CANCER - A PHASE-II STUDY IN PREVIOUSLY UNTREATED PATIENTS - A NATIONAL CANCER INSTITUTE OF CANADA CLINICAL-TRIALS GROUP-STUDY [J].

BLACKSTEIN, M ;

EISENHAUER, EA ;

WIERZBICKI, R ;

YOSHIDA, S .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) :385-389

[3] TENIPOSIDE (VM-26), AN OVERLOOKED HIGHLY-ACTIVE AGENT IN SMALL-CELL LUNG-CANCER - RESULTS OF A PHASE-II TRIAL IN UNTREATED PATIENTS [J].

BORK, E ;

HANSEN, M ;

DOMBERNOWSKY, P ;

HANSEN, SW ;

PEDERSEN, AG ;

HANSEN, HH .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) :524-527

[4]

BORK E, 1989, P ASCO, V8, P229

[5]

CLARK P, 1988, LUNG CANCER, V4, pA108

[6]

COHEN EA, 1985, P AM SOC CLIN ONCOL, V4, P1190

[7]

CREECH RH, 1984, CANCER TREAT REP, V68, P1183

[8]

CULLEN M, 1989, LUNG CANCER, V5, P1

[9]

CULLEN MH, 1987, CANCER TREAT REP, V71, P1227

[10]

ETTINGER DS, 1990, IN PRESS P AM SOC CL